Lemberg A, Schreier L, Romay S, Fernández MA, Rosello D, Gonzales S, Perazzo JC, Filinger EJ, Lujan TM

Language: English
References: 52
Page: 227-232
PDF size: 122.96 Kb.

Text Extraction

Lipoproteins are synthesized by the liver and secreted to plasma. Chronic alcoholic intoxication produces frequently cirrhosis and concomitantly alterations in liver metabolism. Thirty patients with alcoholic cirrhosis and 83 healthy controls were selected for this study. Apolipoprotein A1, B100, lecithin cholesterol acyltransferase, responsible for cholesterol esterification and seudocholinesterase enzyme activity not related to lipid metabolism, as a referent of proteins synthesized by the liver were analyzed. In 7 patients serum tiobarbituric acids, catalase, glutathione peroxidase were measured, as exponent of the presence of oxidative stress. Our results showed a significant decrease in lipoproteins, lecithin cholesterol acyltransferase and seudocholinesterase activities. An increase in serum tiobarbituric acids and a decrease in both antioxidant enzymes were found as well. In conclusion, alcohol cirrhotic liver decreases the production of liver proteins including those related to lipid metabolism, allowing the formation of steatosis and/or necrosis. Moreover oxidative stress participate possible as a major mechanism in liver damage.

REFERENCES

1. Greten H. Biochemistry, metabolism, epidemiology, pp 1 – 10 in lipoproteins and coronary heart disease, edited H. Greten, PD. Lang, G. Schettler. Gerhard Witzstrock – Publishing House, New York, Baden Baden, Cologne 1980.

2. Bremer HB, Schaefer EJ, Zech LA, Osborne JC. Human plasma lipoproteins, structure function and metabolism, pp 7 – 15 in lipoproteins and coronary heart disease, edited H. Greten, PD. Lang, G. Schettler. Gerhard Witzstrock – Publishing House, New York, Baden Baden, Cologne 1980.

3. Kroon P A, Powell EE. Liver lipoproteins and disease. Biochemistry of lipoprotein metabolism. Hepatol 1992; 7: 214-24.

4. Schreier L. Sobre el perfil de las subfracciones lipoproteicas plasmáticas, Papel del hígado; in Lipoproteínas. Academia Nacional de Ciencias, Bs. As, Argentina. 2004; 57: 17-24.

5. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35: 898-904.

6. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol. 2000; 32(S): 39-47.

7. Hezode C, Roudot-Thoraval F, Zafrani ES, Dhumeaux D, Pawlotsky JM. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. J Viral Hepat 2004; 11: 455-8.

8. Walsh MJ, Vanags DM, Clouston AD, Richardson MM, Purdie DM, Jonsson JR, Powell EE. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology 2004; 39: 1230-8.

9. Crocker JFS. Reye‘s syndrome. Seminars in Liver Disease, 1982; 2: 340-52.

10. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002; 65: 166-76.

11. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004; 126: 586-97.

12. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35: 898-904.

13. Wu D, Cederbaum AI. Alcohol, oxidative stress, and free radical damage. Alcohol Res Health 2003; 27: 277-84.

14. Fernandez-Checa JC. Alcohol- induced liver disease: When fat and oxidative stress meet. Annals of Hepatology 2003; 2: 69-75.

15. Kaplowitz N, Tsukamoto H. Oxidative stress and liver disease. Prog Liver Dis 1996; 14: 131-59.

16. Tuma DJ, Casey CA. Dangerous byproducts of alcohol breakdown-focus on adducts. Alcohol Res Health 2003; 27: 285-90.

17. Neuman MG. Cytokines-central factors in alcoholic liver disease. Alcohol Res Health 2003; 27: 307-16.

18. De Groot H. Reactive oxygen species in tissue injury. Hepatogastroenterology 1994; 41: 328-32.

19. Fernandez-Checa JC, Kaplowitz N, Colell A, Garcia-Ruiz C. Oxidative stress and alcoholic liver disease. Alcohol Health Res World 1997; 21: 321-4.

20. Adachi M, Ishii H. Role of mitochondria in alcoholic liver injury. Free Radical Biol Med 2002; 32: 487-91.

21. Dringen R, Gutteres JM, Hinrenger. Glutathione metabolism in brain: interaction between astrocytes and neurons in the defense, against reactive oxygen species. Eur J Biochem 2001; 967: 4910-16.

22. Fernandez-Checa JC, Kaplowitz N. Hepatic mitochondrial glutathione: transport and role in disease and toxicity. Toxicology and Applied Pharmacology 2005; 204: 263-73.

23. Hirano T, Kaplowitz N, Tsukamoto H, Kamimura S, Fernandez-Checa J. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 1992; 16: 1423-7.

24. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Wiliams R. Transection of the oesophagus for bleeding oesophageal varices. Brit J Surg 1973; 60: 646-54.

25. Lowry HO, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin reagent. J Biol Chem 1951; 193: 265-75.

26. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.

27. Flohé L, Gunzler WA. Assays of glutathione peroxidase. Meth Enzymol 1984; 105: 114-21.

28. Buege JA, Aust SD. Microsomal lipid peroxidation. Meth Enzymol 1978; 52: 302-10.

29. Mathur SN, Born E, Murthy S, Field FJ. Phosphatidylcholine increase the secretion of triacyl-glyceron-rich lipoproteins by CaCo-2 cells. Biochem J 1996; 314: 569-75.

30. Zhou Z, Luchoomun J, Bakillah A, Hussain MM. Lysophosphatidylcholine increases apolipoprotein B secretion by enhancing lipid synthesis and decreasing its intracellular degradation in HepG2 cells. Biochimica et Biophysica Acta 1998; 1391: 13-24.

31. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271: 518-20.

32. Arai T, Wang N, Bezouevski M, Welch C, Tall AR. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 1999; 274: 2366-71.

33. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387: 414-7.

34. Nibbering CP, Groen AK, Ottenhoff R, Brouwers JF, vanBerge-Henegouwen GP, van Erpecum KJ. Regulation of biliary cholesterol secretion is independent of hepatocyte canalicular membrane lipid composition: a study in the diosgenin-fed rat model. J Hepatol 2001; 35: 164-9.

35. Berg GA. Lipasa hepática, efectos sobre el metabolismo lipídico y lipoproteico. Acta Bioq Clin Latinoam 2001; 35: 201-24.

36. Thierry C, Yusuke I, Barbier O, Duran-Sandoval D, Kosykh V, Fruchart J, Fruchart JC, Gonzalez FJ, Staels B. Farnesoid X receptor agonists suppress hepatic apolipoproteína CIII expression. Gastroenterology 2003; 125: 544-55.

37. Oude Elferink RP, Groen AK. Mechanisms of biliary lipid secretion and their role in lipid homeostasis. Semin Liver Dis 2000; 20: 293-305.

38. Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1996; 1302:93-109.

39. Handschin C, Meyer UA. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch Biochem Biophys 2005; 433: 387-96.

40. Cunard R, Ricote M, DiCampli D, Archer DC, Kahn DA, Glass CK, Kelly CJ. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J Immunol 2002; 168: 2795-802.

41. Peelman F, Vandekerckhove J, Rosseneu M. Structure and function of lecithin cholesterol acyl transferase: new insights from structural predictions and animal models. Curr Opin Lipidol 2000; 11: 155-60.

42. Glomset JA, Janssen EJ, Kennedy R, Dobbins J. Role of plasma lecithin cholesteryl acyl transferase in the metabolismof high density lipoproteins. J Lip Res 1966; 7: 638-48.

43. Brites F, Fernandez K, Yael M, Wikinski R. Evolution of a patient with a partial deficiency of lecithin acyl cholesterol transferase. Medicina 2000; 60: 406-7.

44. De Vries R, Borggreve SE, Dullaart RP. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus. Clin Lab 2003; 49: 601-13.

45. McCord JM. Iron, free radicals, and oxidative injury. J Nutr 2004; 134: 3171S-2S.

46. Zhao P, Kahon TF, Slattery JI. Selective mitochondrial glutathione depletion by ethanol, enhances acetoaminophen toxicity in rat liver. Hepatology 2002; 36: 326-35.

47. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colelli A. Mitochondrial glutathione importance and transport. Semin liver Dis 1998; 18: 389-401.

48. Fernandez-Checa JC, Garcia-Ruiz C, Ookhtens M, Kaplowitz N. Impaired uptake of glutathione by hepatic mitochondria from chronic etanol-fed rats. Tracer kinetic stiudies in vitro and in vivo and susceptibility to oxidant stress. J Clin Invest 1991; 87: 397-403.

49. Krähenbühl S, Talos C, Lauterburg BH, Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 1995; 22: 607-12.

50. Bengoechea L, Ouviña G, Zozzami P, Lemberg A. Protein and lipid disturbance in rat liver microsomal membranes after bile duct ligation. Biochem Biosphys Res Comm 1987; 144: 980-5.

51. Mari M, Caballero F, Colleli A, Morales A, Caballero J, Fernandez-Checa JC, Garcia-Ruiz C. Mitochondrial free cholesterol loading sensitizes to TNF and Fas mediated steatohepatitis. Cell Metab 2006; 4: 179-81.

52. Meagher EA, Barry OP, Burke A, Lucey MR, Lawson JA, Rokach J, FitzGerald GA. Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest 1999; 104: 805-13.